Effect of morphine on striatal dopamine metabolism and ascorbic acid and uric acid release in freely moving rats

Brain Research

Volumn 745, Issue 1-2, 1997, Pages 173-182

  Enrico, Paolo ^a   Esposito, Giovanni ^a   Mura, Maria A ^a   Fresu, Luigia ^a   De Natale, Guglielmo ^a   Miele, Egidio ^a   Desole, Maria S ^a   Miele, Maddalena ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Ascorbic acid; Dopamine xanthine metabolism; In vivo; Morphine; Striatum release; Uric acid

Indexed keywords

ASCORBIC ACID; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; MORPHINE; URIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; MALE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ASCORBIC ACID; DOPAMINE; HOMOVANILLIC ACID; MALE; MICRODIALYSIS; MORPHINE; NARCOTICS; NEOSTRIATUM; RATS; RATS, WISTAR; URIC ACID;

EID: 0031015660     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01146-8     Document Type: Article

References (43)

1. Acquas, E. and Di Chiara, G., Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence, J. Neurochem., 58 (1992) 1620-1625.
2. Aghajanian, G.K., Kogan, J.H. and Moghaddam, B., Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study, Brain Res., 636 (1994) 126-130.
3. Ahtee, L. and Attila, L.M.J., Cerebral monoamine neurotransmission in opioid withdrawal and dependence, Med. Biol., 65 (1987) 113-119.
4. Ahtee, L., Attila, L.M.J., Carlson, K.R. and Haikala, H., Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawal state, J. Pharmacol. Exp. Ther., 249 (1989) 303-310.
5. Attila, L.M.J. and Ahtee, L., Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 327 (1984) 201-207.
6. Becker, B.B., Towards the physiological function of uric acid, Free Rad. Biol. Med., 14 (1993) 615-631.
7. Chiueh, C.C., Auto-oxidation of dopamine and formation of free radicals in vivo. In A. Louilot A., T. Durkin, U. Spampinato and M. Cador (Eds.), Monitoring Molecules in Neuroscience, Universities of Bordeaux, 1994 pp. 127-128.
8. De Angeli, L., Ascorbic acid and atypical antipsychotic drugs: modulation of aminopeptine-induced behavior in mice, Brain Res., 670 (1995) 303-307.
9. de Lange, E.C.M., Danhof, M., Zurcher, C., de Boer, A.G. and Breimer, D.D., Repeated microdialysis perfusions: periprobe tissue reactions and BBB permeability, Brain Res., 702 (1995) 261-265.
10. Desole, M.S., Esposito, G., Migheli, R., Fresu, L., Sircana, S., Miele, M., De Natale, G. and Miele, E., Allopurinol protects against manganese-induced oxidative stress in the striatum and in the brainstem of the rat, Neurosci. Lett., 192 (1995) 73-76.
11. Desole, M.S., Esposito, G., Fresu, L., Migheli, R., Enrico, P., Mura, M.A., De Natale, G., Miele, E. and Miele, M., Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat, Brain Res., 723 (1996) 154-161.
12. Di Chiara, G. and Imperato, A., Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats, J. Pharmacol. Exp. Ther., 244 (1988) 1067-1080.
13. Diliberto, E.J. Jr., Dean, G., Carter, C. and Allen, P., Tissue, subcellular and submitochondrial distribution of semidehydroascorbate reductase: possible role of semidehydroascorbate reductase in cofactor regeneration, J. Neurochem., 39 (1982) 563-568.
14. Duff, A. and O'Neill, R.D., Effect of probe size on the concentration of brain extracellular uric acid monitored with carbon paste electrode, J. Neurochem., 62 (1994) 1496-1502.
15. Gunne, L.H., Jonsson, J. and Fuxe, K., Morphine intoxication on brain catecholamines neurones, Eur. J. Pharmacol., 5 (1969) 338-342.
16. Gysling, K. and Wang. R.Y., Morphine-induced activation of AlO dopamine neurons in the rat, Brain Res., 277 (1983) 119-127.
17. Honkanen, A., Piepponen, T.P. and Ahtee, L., Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment, Neurosci. Lett., 180 (1994) 119-122.
18. Johnson, S.W. and North, R.A., Opioids excite dopamine neurons by hyperpolarization of local interneurones, J. Neurosci., 12 (1992) 483-488.
19. Johnston, P.A. and Chahl, L.A., Chronic treatment with ascorbic acid inhibits the morphine withdrawal response in guinea-pigs, Neurosci. Lett., 135 (1992) 23-37.
20. Kalivas, P.W. and Stewart, J., Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity, Brain Res. Rev., 16 (1991) 223-244.
21. Khanna, N.C. and Sharma, S.K., Megadoses of vitamin C prevent the development of tolerance and physical dependence on morphine in mice, Life Sci., 33 (1983) 401-404.
22. Koob, G.F., Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol. Sci, 13 (1992) 177-184.
23. Lam, D.K.C. and Daniel, P.M., The influx of ascorbic acid into the rat brain, Q. J. Exp. Physiol., 71 (1986) 483-490.
24. Libby, A.F. and Stone L., The hypoascorbemia-kwashiorkor approach to drug addiction therapy: a pilot study, J. Orthomol. Psychiatry, 6 (1977) 300-308.
25. Marek, P., Ben-Eliyahu, S., Gold, M. and Liebeskind, J.C., Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat, Brain Res., 547 (1991) 77-81.
26. Miele, M., Boutelle, M.G. and Fillenz, M., The physiologically-induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake, Neuroscience, 62 (1994) 87-91.
27. Miele, M., Enrico, P., Esposito, G., Fresu, L., Migheli, R., De Natale G. and Desole M.S., Cortical ablation and drug-induced changes in striatal ascorbic acid oxidation and behavior in the rat, Pharmacol. Biochem. Behav., 50 (1995) 1-7.
28. Miele, M. and Fillenz, M., In vivo determination of extracellular brain ascorbate, J. Neurosci. Methods, 69 (1996) 21-24.
29. Niki, E., Action of ascorbic acid as a scavenger of active and stable oxygen radicals, Am. J. Clin. Nutr., 54 (1991) 1119S-1124S.
30. O'Neill, R.D., Uric acid and dopamine transmission in rat striatum: diurnal changes and effects of drugs, Brain Res., 507 (1990) 267-272.
31. Paxinos, G. and Watson, C., Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
32. Pierce, R.C., Clemens, A.J., Shapiro, L.A. and Rebec, G.V., Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats, Psychopharmacology, 116 (1994) 103-109.
33. Rebec, G.V. and Pierce, C.P., A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission, Prog. Neurobiol., 43 (1994) 537-565.
34. Roginsky, V.A., Barsukova, T.K., Bruchelt, G. and Stegmann, H.B., Interaction of catecholamines and 6-hydroxydopamine with ascorbate during autoxidation, Pharmacol. Res., 31 (S) (1995) 141.
35. Rossetti, Z.L., Hmaidan, Y. and Gessa, G.L., Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rat, Eur. J. Pharmacol., 221 (1992) 227-234.
36. Sevanian, A., Davies, K.J.A. and Hochstein P., Serum urate as an antioxidant for ascorbic acid, Am. J. Clin. Nutr., 54, (1991) 129S-134S.
37. Shenk, J.O., Miller, E. Gaddis, E. and Adams, R.N., Homeostatic control of ascorbate concentrations in CNS extracellular fluid, Brain Res., 253 (1982) 353-356.
38. Spanagel, R., Almeida, O.F.X. and Shippenberg, T.S., Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure, Synapse, 14 (1993) 243-245.
39. Spector R., Penetration of ascorbic acid from cerebrospinal fluid into brain, Exp. Neurol., 72 (1982) 645-653.
40. Spina, M.B. and Cohen, G., Dopamine turnover and glutathione oxidation: Implication for Parkinsons's disease, Proc. Natl. Acad. Sci. USA, 87 (1989) 1398-1400.
41. Tanganelli, S., Antonelli, T., Morari, M., Bianchi, C. and Beani, L., Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs, Neurosci. Lett., 122 (1991) 270-272.
42. Trujillo, K.A. and Akil, H., Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801, Science, 251 (1991) 85-87.
43. Yonehara, N. and Clouet, D.H., Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum, J. Pharmacol. Exp. Ther., 231 (1984) 38-42.